Ganglioside GD2 antibody (PE-Cy7)

Catalog No. ABIN2667320

This anti-Ganglioside GD2 antibody is a Mouse Monoclonal antibody detecting Ganglioside GD2 in FACS. Suitable for Human.

Quick Overview for Ganglioside GD2 antibody (PE-Cy7) (ABIN2667320)

Target: Ganglioside GD2

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This Ganglioside GD2 antibody is conjugated to PE-Cy7

Application: Flow Cytometry (FACS)

Clone: 14G2a

Product Details anti-Ganglioside GD2 Antibody (PE-Cy7)

Purification: The antibody was purified by affinity chromatography and conjugated with PE/Cy7 under optimal conditions. The solution is free of unconjugated PE/Cy7 and unconjugated antibody.

Isotype: IgG2a kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from prolonged exposure to light. Do not freeze.

Storage: 4 °C

Storage Comment: The antibody solution should be stored undiluted between 2°C and 8°C.

Target Details for Ganglioside GD2

Target: Ganglioside GD2

Background: Ganglioside GD2 is a sialic acid-containing glycosphingolipid involved in cell attachment to the extracellular matrix. Expression of GD2 in normal tissue is restricted to cells from the central nervous system, peripheral nerves, skin melanocytes, and mesenchymal stem cells. However GD2 is highly expressed by tumors of neuro-ectodermal origin such as melanomas, gliomas, neuroblastomas, and small cell lung carcinoma. GD2 has been proposed as a marker for some cancer stem cells.